Menu

Experience

Heidi A. Erlacher

    • Cooley Advises on Nightstar + NuCana IPOs 


    • Zealand Pharma – $89 Million IPO 


    • Recro Pharma – $15 Million Follow-On  


    • Syros – $58 Million IPO 


    • Syros IPO – $58 Million 


    • WAVE Life Sciences - $102 Million IPO 


    • Axovant Completes $362 Million IPO 


    • Minerva – $58 Million Follow-On Offering 


Contact us

Back to top

© 2019 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.